NASDAQ: CRVS
Corvus Pharmaceuticals Inc Stock Ownership - Who owns Corvus Pharmaceuticals?

Insider buying vs selling

Have Corvus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
William Benton JonesSVP Pharmaceutical Development2024-05-0620,000$1.73
$34.62kBuy
Richard A. Md MillerPresident and CEO2024-05-06577,634$1.73
$999.88kBuy

1 of 1

CRVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRVS insiders and whales buy or sell their stock.

CRVS Shareholders

What type of owners hold Corvus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter A. Thompson10.19%6,943,654$22.36MInsider
Orbimed Advisors LLC10.19%6,943,654$22.36MInsider
Orbimed Advisors LLC10.19%6,943,654$22.36MInstitution
Samlyn Capital LLC9.79%6,667,105$21.47MInstitution
Ecor1 Capital LLC7.58%5,162,154$16.62MInsider
Terry P. Gould4.99%3,402,422$10.96MInsider
Adams Street Partners LLC4.99%3,402,422$10.96MInsider
Adams Street Partners LLC4.81%3,275,616$10.55MInstitution
Point72 Asset Management LP4.45%3,030,011$9.76MInstitution
Rtw Investments LP3.93%2,679,479$8.63MInstitution

1 of 3

CRVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRVS55.31%44.07%Net Buying
DSGN45.50%54.50%Net Selling
CADL37.95%33.37%Net SellingNet Selling
LXRX25.27%74.73%Net SellingNet Selling
OABI52.05%26.35%Net BuyingNet Buying

Corvus Pharmaceuticals Stock Ownership FAQ

Who owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals (NASDAQ: CRVS) is owned by 55.31% institutional shareholders, 44.07% Corvus Pharmaceuticals insiders, and 0.62% retail investors. Peter A. Thompson is the largest individual Corvus Pharmaceuticals shareholder, owning 6.94M shares representing 10.19% of the company. Peter A. Thompson's Corvus Pharmaceuticals shares are currently valued at $23.12M.

If you're new to stock investing, here's how to buy Corvus Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.